Trials / Completed
CompletedNCT03525236
The Oncoflavour Study
Product Validation by Cancer Patients - Oncoflavour
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Oral nutritional supplements (ONS) are often prescribed for malnourished patients to help improve nutritional status. Commonly in cancer patients taste and smell alterations and side effects of treatment can affect the palatability and compliance to ONS. A variety of flavours and styles are available of ONS however research of the palatability of these in cancer patients is limited. This study aims to evaluate specific flavours created based on the taste changes occuring during treatment. We aim to evaluate the patient liking and evaluation of 5 flavors in 3 different types of flavour-sensations: * Warming/spicy sensation: to trigger the senses and bring new sensations * Cooling/fresh sensation: to have a fresh mouthfeel and lighter base perception * Neutral: to avoid that patients experience additional flavour and let them the opportunity to mix it with other food
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Tasting of flavours | * Each patient will taste 5 products, in sequential-monadic test, randomized, one by one. * Patients will take few sips of each study product, ideally in isolation (avoid influence of other patients) * For each product tasted the subjects will be asked to answer a questionnaire including 1 question on the palatability of the product using a 10-point hedonic scale and a more detailed organoleptic evaluation of the product. * Between product tastings, participants will have a 10 minutes break to rinse their mouth and fill in a questionnaire assessing sensory changes |
Timeline
- Start date
- 2017-06-19
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2018-05-15
- Last updated
- 2024-04-19
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03525236. Inclusion in this directory is not an endorsement.